GSB Podium Advisors’s Eli Lilly LLY Stock Holding History

GSB Podium Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-5,357	Closed	-$263K	–	13
2013 Q2	$263K	Buy	+5,357	New	+$291K	9.49%	2

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GSB Podium Advisors's LLY Position: Q3 2013 in Review

GSB Podium Advisors sold out of Eli Lilly (LLY) in Q3 2013, closing a stake of 5,357 shares — an estimated $263K sold.

GSB Podium Advisors first reported a position in LLY in Q2 2013 and held it in 1 quarter. The position peaked at $263K in Q2 2013. 973 funds tracked by Wall St. Rank hold LLY as of Q3 2013.

GSB Podium Advisors reported no remaining Eli Lilly position as of Q3 2013 after selling out during the quarter.
GSB Podium Advisors sold 5,357 Eli Lilly shares in Q3 2013, an estimated $263K.
GSB Podium Advisors first reported a position in Eli Lilly in Q2 2013 and held it in 1 quarter.
GSB Podium Advisors's Eli Lilly position peaked at $263K in Q2 2013.
973 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2013.

Based on GSB Podium Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.